Ask AI
ProCE Banner Activity

Improving Outcomes in CRSwNP: Understanding Disease Pathogenesis and the Emerging Role of Biologics

Clinical Thought

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory condition that often occurs via the type 2 inflammation pathway. Learn how the pathogenesis of this disease is informing the role of emerging targeted biologics to improve outcomes for patients with CRSwNP.

Released: June 27, 2025

Expiration: June 26, 2026

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with Snot Force Alliance, Inc.

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Partners

Snot Force Alliance, Inc.

ProCE Banner

Disclosure

Primary Author

Anju Peters, MD, MSCI: consultant/advisor/speaker: AstraZeneca, Chiesi, GlaxoSmithKline, Lilly, Regeneron, Sanofi; researcher: AstraZeneca, Regeneron, Sanofi.